rs113994204
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM4PP5_Very_Strong
The NM_004937.3(CTNS):c.198_218del(p.Ile67_Pro73del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.0000254 in 1,613,814 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000026 ( 0 hom. )
Consequence
CTNS
NM_004937.3 inframe_deletion
NM_004937.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.93
Genes affected
CTNS (HGNC:2518): (cystinosin, lysosomal cystine transporter) This gene encodes a seven-transmembrane domain protein that functions to transport cystine out of lysosomes. Its activity is driven by the H+ electrochemical gradient of the lysosomal membrane. Mutations in this gene cause cystinosis, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_004937.3.
PP5
Variant 17-3648903-ATATTACTATCCTTGAGCTCCC-A is Pathogenic according to our data. Variant chr17-3648903-ATATTACTATCCTTGAGCTCCC-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 21438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-3648903-ATATTACTATCCTTGAGCTCCC-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTNS | NM_004937.3 | c.198_218del | p.Ile67_Pro73del | inframe_deletion | 5/12 | ENST00000046640.9 | NP_004928.2 | |
LOC105371493 | XR_007065579.1 | n.1934+1240_1934+1260del | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTNS | ENST00000046640.9 | c.198_218del | p.Ile67_Pro73del | inframe_deletion | 5/12 | 1 | NM_004937.3 | ENSP00000046640 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152214
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251472Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135918
GnomAD3 exomes
AF:
AC:
5
AN:
251472
Hom.:
AF XY:
AC XY:
2
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461600Hom.: 0 AF XY: 0.0000220 AC XY: 16AN XY: 727142
GnomAD4 exome
AF:
AC:
38
AN:
1461600
Hom.:
AF XY:
AC XY:
16
AN XY:
727142
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74370
GnomAD4 genome
AF:
AC:
3
AN:
152214
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nephropathic cystinosis Pathogenic:3Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Dec 27, 2019 | NM_001031681.2(CTNS):c.198_218del21(aka I67_P73del) is classified as likely pathogenic in the context of cystinosis and is associated with a less severe form of disease. Sources cited for classification include the following: PMID 18178779‚Äé, 9792862, 21305353 and 15128704. Classification of NM_001031681.2(CTNS):c.198_218del21(aka I67_P73del) is based on the following criteria: There is strong evidence of association with the variant and the relevant disease. Please note: this variant was assessed in the context of healthy population screening. - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 22, 2023 | - - |
Cystinosis Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 11, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 09, 2018 | Variant summary: CTNS c.198_218del21 (p.Ile67_Pro73del) results in an in-frame deletion that is predicted to remove ITILELP amino acids from the encoded protein. c.198_218del21 has been reported in the literature in multiple individuals affected with Cystinosis as both a homozygous and compound heterozygous allele. These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Juvenile nephropathic cystinosis;C2931013:Ocular cystinosis;C2931187:Nephropathic cystinosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 16, 2021 | - - |
Juvenile nephropathic cystinosis;C0950123:Inborn genetic diseases;C2931013:Ocular cystinosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This variant, c.198_218del, results in the deletion of 7 amino acid(s) of the CTNS protein (p.Ile67_Pro73del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs113994204, gnomAD 0.006%). This variant has been observed in individual(s) with cystinosis (PMID: 9792862, 28629674). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 21438). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects CTNS function (PMID: 15128704). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at